NOT ALL CATHETERS ARE CREATED EQUAL.€¦ · not all catheters . are created equal. trust...
2
™ NOT ALL CATHETERS ARE CREATED EQUAL. TRUST POWERWAND WWW.ACCESSSCIENTIFIC.COM [email protected] (858) 259-8333 SHOWN TO INHIBIT BACTERIAL ATTACHMENT (IN VITRO) 1 SHOWN TO REDUCE THROMBUS FORMATION (IN VIVO) 2 OVER 35,000 CATHETER DAYS WITH ZERO BSIs ‡ FAST AND EASY INSERTION ONE STICK HOSPITALIZATION UNPARALLELED POWER INJECTION PERFORMANCE (8ML/SEC, 325 PSI) KINK RESISTANCE HIGH FLOW (130-180 ML/MIN) BLOOD DRAWABILITY
Transcript of NOT ALL CATHETERS ARE CREATED EQUAL.€¦ · not all catheters . are created equal. trust...
™
NOT ALL CATHETERS ARE CREATED EQUAL.
TRUST POWERWAND
WWW.ACCESSSCIENTIFIC.COM [email protected] (858) 259-8333
SHOWN TO INHIBIT BACTERIAL ATTACHMENT (IN VITRO)1
SHOWN TO REDUCE THROMBUS FORMATION (IN VIVO)2
OVER 35,000 CATHETER DAYS WITH ZERO BSIs‡
FAST AND EASY INSERTION ONE STICK HOSPITALIZATION
UNPARALLELED POWER INJECTION PERFORMANCE (8ML/SEC, 325 PSI)
KINK RESISTANCE HIGH FLOW (130-180 ML/MIN) BLOOD DRAWABILITY
THE POWERWAND – A CATHETER WITHOUT EQUAL.
Blood Drawability:60-99%‡ blood drawability
for full length of stay
Infection Prevention:Zero BSIs over 35,000 catheter-days (and counting)‡
Catheter material: ChronoFlex C® with BioGUARD™ Technology is proven to inhibit bacterial attachment (in vitro)1
High Flow:Highest flow rates of any midline
catheter: up to 180 mL/min
Power Injection:The best power injection
performance rating on the market: 8mL/sec, 325 psi
BioGUARD™ Technology70% reduction
in bacterial attachment¹
Polyurethane*
Clean:POWERWAND is shown to inhibit bacterial attachment (in vitro)1 and is thromboresistant2
Kink Resistant:Unlike other catheters, the unique material of the POWERWAND catheter is highly kink resistant, allowing for reliability during both insertion and dwell time
POWERWAND material
Standard catheter material
POWERWAND Catheter
Trimmed Catheter
Non-Trimmable:No trimming means a reduction in DVTs‡; there are no jagged edges on the thermoformed POWERWAND catheter 1. Proven in vitro to significantly (p=0.0133) inhibit bacterial attachment and biofilm
formation† as compared with a commonly used polyurethane catheter*.2. The POWERWAND is proven in vivo to be thromboresistant with respect to both thrombuson the surface of the catheter and thrombus on the wall of the vein. Based on canine jugularvein thromboresistance study, correlations to clinical applications has not been ascertained.† Based on laboratory test results which may not be indicative of clinical results. Data on file
and refer to publication³. Preclinical in-vitro evaluations do not necessarily predict clinicalperformance with respect to catheter-related bloodstream infection.
3. Pathak R, Bierman S, d’Arnaud P. Inhibition of bacterial attachment and biofilm formation bya novel intravenous catheter material using an in vitro percutaneous catheter insertion model.
Medical Devices: Evidence and Research. 2018;11:1-6.https://doi.org/10.2147/MDER.S183409.
4. Moureau N, Sigl G, Hill M. How to Establish an Effective Midline Program: A Case Study of 2 Hospitals. JAVA 2015; 20(3):179-188.
5. Pathak R, Patel A, Enuh H, et al. The Incidence of Central Line–Associated Bacteremia After the Introduction of Midline Catheters in a Ventilator Unit Population.
Infect Dis Clin Prac 2015;23(3): 131-134.
* PowerGlide® (CR Bard, Salt Lake City, UT) - a registered trademark of C.R. Bard.
POWERWAND™ and BioGUARD™ are trademarks of Access Scientific, LLC.
ChronoFlex C® is a registered trademark of AdvanSource Biomaterials Corp.‡Data on File.
Echogenic:Echogenic properties of
POWERWAND catheter allows for ultrasound visualization once in the vein
Cost Savings:Due to its performance, the POWERWAND resulted in an estimated $448,000-$531,570 of annual savings4, 5
100 µm 100 µm
LC-0392 Rev. F
